The CD1 family and T cell recognition of lipid antigens

Tissue Antigens

Volumn 60, Issue 5, 2002, Pages 337-353

  Dutronc, Y ^a   Porcelli, Steven A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adaptive immunity; CD1; Glycolipid; Innate immunity; Lipid; NK T cell; T cell

Indexed keywords

ANTIGEN; BACTERIAL ANTIGEN; BETA 2 MICROGLOBULIN; BETA 2 MICROGLOBULIN ASSOCIATED TRANSMEMBRANE PROTEIN; CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; CD1E ANTIGEN; GLYCOLIPID; LIPID ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE ANTIGEN; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN; UNCLASSIFIED DRUG;

ALPHA HELIX; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; DENDRITIC CELL; ENDOSOME; IMMUNE SYSTEM; LYSOSOME; MOLECULAR INTERACTION; NATURAL KILLER CELL; PARASITOSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION; TUMOR IMMUNITY; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; AUTOIMMUNE DISEASES; KILLER CELLS, NATURAL; LIPIDS; MICE; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0036867766     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.600501.x     Document Type: Review

References (80)

1. Porcelli SA, Modlin RL. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999: 17: 297-329.
2. Calabi F, Milstein C. The molecular biology of CD1. Semin Immunol 2000: 12: 503-9.
3. Calabi F, Jarvis JM, Martin L, Milstein C. Two classes of CD1 genes. Eur J Immunol 1989: 19: 285-92.
4. Angenieux C, Salamero J, Fricker D et al. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem 2000: 275: 37757-64.
5. Brossay L, Jullien D, Cardell S et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 1997: 159: 1216-24.
6. Exley M, Garcia J, Wilson SB et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000: 100: 37-47.
7. Blumberg RS, Terhorst C, Bleicher P et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol 1991: 147: 2518-24.
8. Bonish B, Jullien D, Dutronc Y et al. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol 2000: 165: 4076-85.
9. Sugita M, Grant EP, van Donselaar E et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999: 11: 743-52.
10. Salamero J, Bausinger H, Mommaas AM et al. CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. J Invest Dermatol 2001: 116: 401-8.
11. Sugita M, Jackman RM, van Donselaar E et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 1996: 273: 349-52.
12. Briken V, Jackman RM, Watts GFM, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000: 192: 281-8.
13. Briken V, Jackman RM, Dasgupta S, Hoening IE, Porcelli SA. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J 2002: 21: 825-34.
14. Sugita M, Cao X, Watts GF, Rogers RA, Bonifacino JS, Brenner MB. Failure of trafticking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 2002: 16: 697-706.
15. Hiromatsu K, Dascher CC, Sugita M et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 2002: 106: 159-72.
16. Brossay L, Tangri S, Bix M, Cardell S, Locksley R, Kronenberg M. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1 + targets. J Immunol 1998: 160: 3681-8.
17. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mahr R, Bendelac A. CD1d endosomal trafticking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001: 15: 897-908.
18. Kang SJ, Cresswell P. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J 2002: 21: 1650-30.
19. + T cell selection and maturation by cathepsin S. Immunity 2001: 15: 909-19.
20. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994: 372: 691-4.
21. Moody DB, Besra GS. Glycolipid targets of CD1-mediated T-cell responses. Immunology 2001: 104: 243-51.
22. Moody DB, Uirichs T, Muhlecker W et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000: 404: 884-8.
23. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G. Self glycolipids as T-cell auto-antigens. Eur J Immunol 1999: 29: 1667-75.
24. Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G. Presentation of the same glycolipid by different CD1 molecules. J Exp Med 2002: 195: 1013-21.
25. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997: 278: 1626-9.
26. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998: 188: 1529-34.
27. Benlagha K, Bendelac A. CD1d-restricted mouse Vα14 and human Vα24 T cells: Lymphocytes of innate immunity. Semin Immunol 2000: 12: 537-42.
28. Schofield L, McConville MJ, Hansen D et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999: 283: 225-9.
29. Gumperz JE, Roy C, Makowska A et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000: 12: 211-21.
30. Joyce S, Woods AS, Yewdell JW et al. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol. Science 1998: 279: 1541-4.
31. De Silva AD, Park JJ, Matsuki N et al. Lipid protein interactions: The assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J Immunol 2002: 168: 723-33.
32. Roberts TJ, Sriram V, Spence PM et al. Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT Cells. J Immunol 2002: 168: 5409-14.
33. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 1997: 277: 339-45.
34. Gadola SD, Zaccai NR, Harlos K et al. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 2002: 3: 721-6.
35. Moody D, Besra GS, Wilson IA, Porcelli SA. The molecular basis of CD1-mediated presentation of lipid antigens. Immunol Rev 1999: 172: 285-96.
36. Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol 1998: 161: 5124-8.
37. Grant EP, Degano M, Rosat JP et al. Molecular recognition of lipid antigens by T cell receptors. J Exp Med 1999: 189: 195-205.
38. Melian A, Watts GF, Shamshiev A et al. Molecular recognition of human CD1b antigen complexes: Evidence for a common pattern of interaction with αβ TCRs. J Immunol 2000: 165: 4494-504.
39. Grant EP, Beckman EM, Behar SM et al. Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex. J Immunol 2002: 168: 3933-40.
40. Burdin N, Brossay L, Degano M et al. Structural requirements for antigen presentation by mouse CD1. Proc Natl Acad Sci U S A 2000: 97: 10156-61.
41. Matsuda JL, Gapin L, Fazilleau N, Warren K, Naidenko OV, Kronenberg M. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor repertoire and small clone size. Proc Natl Acad Sci U S A 2001: 98: 12636-41.
42. Chiu YH, Jayawardena J, Weiss A et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 1999: 189: 103-10.
43. Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med 2001: 193: 893-904.
44. + T lymphocytes. J Immunol 2002: 168: 5514-20.
45. Moody DB, Briken V, Cheng TY et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 2002: 3: 435-42.
46. Sugita M, van Der WN, Rogers RA, Peters PJ, Brenner MB. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci U S A 2000: 97: 8445-50.
47. Naidenko OV, Maher JK, Ernst WA, Sakai T, Modlin RL, Kronenberg M. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med 1999: 190: 1069-80.
48. Ernst WA, Maher J, Cho S et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 1998: 8: 331-40.
49. Prigozy TI, Naidenko O, Qasba P et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001: 291: 664-7.
50. Gumperz JE, Brenner MB. CD1-specific T cells in microbial immunity. Curr Opin Immunol 2001: 13: 471-8.
51. Moody D, Guy MR, Grant E et al. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 2000: 192: 965-76.
52. Sieling PA, Jullien D, Dahlem M et al. CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity. J Immunol 1999: 162: 1851-8.
53. Hiromatsu K, Dascher CC, LeClair KP et al. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 2002: 169: 330-9.
54. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Benner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995: 375: 155-8.
55. Faure F, Jitsukawa S, Miossec C, Hercend T. CD1c as a target recognition structure for human T lymphocytes: Analysis with peripheral blood γ/δ cells. Eur J Immunol 1990: 20: 703-6.
56. Spada FM, Grant EP, Peters PJ et al. Selfrecognition of CD1 by γ/δ T cells: Implications for innate immunity. J Exp Med 2000: 191: 937-48.
57. Matsuda JL, Naidenko OV, Gapin L et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000: 192: 741-54.
58. Nakagawa R, Nagafune I, Tazunoki Y et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol 2001: 166: 6578-84.
59. Burdin N, Brossay IL, Kronenberg M. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 1999: 29: 2014-25.
60. + CD1d-dependent precursor stage. J Exp Med 2002: 195: 835-44.
61. Benlagha K, Kyin T, Beavis A, Teyton IL, Bendelac A. A thymic precursor to the NK T cell lineage. Science 2002: 296: 553-5.
62. Kumar H, Belperron A, Barthold SW, Bockenstedt LK. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000: 165: 4797-801.
63. Nieuwenhuis EE, Matsumoto T, Exley M et al. CD1d-dependent macrophage mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002: 8: 588-93.
64. + αβ T cells in IL-12 production during Salmonella infection. J Immunol 1999: 163: 2057-63.
65. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999: 189: 1973-80.
66. Mempel M, Ronet C, Suarez F et al. Natural killer T cells restricted by the monomorphic MHC class 1b, CD1d1 molecules behave like inflammatory cells. J Immunol 2002: 168: 365-71.
67. Kakimi K, Guidotti LG, Koezulka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000: 192: 921-30.
68. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a non-classical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002: 16: 583-94.
69. Exley MA, He Q, Cheng O et al. Cutting edge: Compartmentalization of Th1-like non-invariant CD1d-reactive T cells in hepatitis C virus-infected liver. J Immunol 2002: 168: 1519-23.
70. Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC et al. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J Exp Med 2002: 195: 617-24.
71. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H. Godfrey DI. NKT cells-conductors of tumor immunity? Curr Opin Immunol 2002: 14: 165-71.
72. Crowe NY, Smyth MJ, Godfrey DI. A critical role for natural killer T Cells in immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002: 196: 119-27.
73. Terabe M, Matsui S, Noben-Trauth N et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000: 1: 515-20.
74. Moodycliffe AM, Nghiern D, Clydesdale G, Ullrich SE. Immune suppression and skin cancer development: Regulation by NKT cells. Nat Immunol 2000: 1: 521-5.
75. Hammond KJ, Godfrey DL. NKT cells: Potential targets for autoimmune disease therapy? Tissue Antigens 2002: 59: 353-43.
76. Singh AK, Wilson MT, Hong S et al. Natural killer T cell activation protects mice against experimental autoimmtme encephalomyelitis. J Exp Med 2001: 194: 1801-11.
77. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001:413: 531-4.
78. Hong S, Wilson MT, Serizawa I et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001: 7: 1052-6.
79. Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001: 7: 1057-62.
80. Naumov YN, Bahjat KS, Gausling R et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A 2001: 98: 13838-43.